Related Experiment Video
Updated: Apr 27, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
Heat-shock protein HSPB1 attenuates microRNA miR-1 expression thereby restoring oncogenic pathways in prostate cancer
Matthias B Stope1, Christian Stender2, Tina Schubert2
1Department of Urology, University Medicine Greifswald, Greifswald, Germany matthias.stope@uni-greifswald.de.
Background:
Heat-shock proteins (HSPs) as well as microRNAs have been identified to orchestrate crucial mechanisms in prostate cancer (PCa) progression and treatment resistance. Due to cytoprotective properties of HSPB1 we analyzed molecular mechanisms of drug resistance in PCa cell culture systems, and notably found HSPB1 functionality linked to microRNA miR-1 activities.
Materials And Methods:
HSPB1 and miR-1 levels were genetically modified in PCa cell lines and alterations in molecular and cellular responses were assessed by quantitative reverse transcription/polymerase chain reaction, western blotting, and proliferation assays.
Results:
Our data provided for the first time evidence that HSPB1 regulates miR-1 expression, and subsequently restores oncogenic signaling pathways of androgen receptor (AR) and transforming growth factor β1 (TGFB1).
Conclusion:
Our data point towards HSPB1 and miR-1 involvement in development of castration-resistant PCa and therefore represent promising targets for anticancer therapy of advanced PCa.
Insights
Heat-shock protein B1 (HSPB1) regulates microRNA 1 (miR-1) in prostate cancer, restoring key signaling pathways. This discovery highlights HSPB1 and miR-1 as potential therapeutic targets for advanced prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Heat-shock proteins (HSPs) and microRNAs are implicated in prostate cancer (PCa) progression and treatment resistance.
- The cytoprotective protein HSPB1's role in PCa drug resistance was investigated, revealing a link to microRNA miR-1 activity.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying drug resistance in prostate cancer.
- To investigate the functional relationship between HSPB1 and miR-1 in PCa.
Main Methods:
- Genetic modification of HSPB1 and miR-1 levels in PCa cell lines.
- Assessment of molecular and cellular responses using quantitative reverse transcription/polymerase chain reaction, western blotting, and proliferation assays.
Main Results:
- Demonstrated for the first time that HSPB1 regulates miR-1 expression.
- Showed that HSPB1-mediated miR-1 regulation restores oncogenic signaling pathways, including androgen receptor (AR) and transforming growth factor β1 (TGFB1).
Conclusions:
- HSPB1 and miR-1 are involved in the development of castration-resistant prostate cancer (CRPC).
- These molecules represent promising therapeutic targets for advanced PCa treatment.
Related Concept Videos
Abnormal Proliferation
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
Hedgehog Signaling Pathway

